Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bitton

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
American Journal of Human Genetics|April 25, 2000
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility lociJ D Rioux, M S Silverberg, M J Daly, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitisR Panaccione, R N Fedorak, G Aumais, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.
ACS Synthetic Biology|January 12, 2021
Mutation Maker, An Open Source Oligo Design Platform for Protein EngineeringKaori Hiraga, Petr Mejzlik, Matej Marcisin, et al.
Genes and Immunity|February 5, 2008
An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29Y Y Shugart, M S Silverberg, R H Duerr, et al.
Genes and Immunity|June 1, 2007
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseasesP L De Jager, D Franchimont, A Waliszewska, et al.
Nature Genetics|October 5, 2001
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn diseaseJ D Rioux, M J Daly, M S Silverberg, et al.
Nature Genetics|February 10, 2015
The genomic and phenotypic diversity of Schizosaccharomyces pombeDaniel C Jeffares, Charalampos Rallis, Adrien Rieux, et al.
Nature Communications|August 10, 2016
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitisManuel A Rivas, Daniel Graham, Patrick Sulem, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
American Journal of Human Genetics|April 25, 2000
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility lociJ D Rioux, M S Silverberg, M J Daly, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitisR Panaccione, R N Fedorak, G Aumais, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2013
Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel diseaseR Khanna, B D Sattin, W Afif, et al.
ACS Synthetic Biology|January 12, 2021
Mutation Maker, An Open Source Oligo Design Platform for Protein EngineeringKaori Hiraga, Petr Mejzlik, Matej Marcisin, et al.
Genes and Immunity|February 5, 2008
An SNP linkage scan identifies significant Crohn's disease loci on chromosomes 13q13.3 and, in Jewish families, on 1p35.2 and 3q29Y Y Shugart, M S Silverberg, R H Duerr, et al.
Genes and Immunity|June 1, 2007
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseasesP L De Jager, D Franchimont, A Waliszewska, et al.
Nature Genetics|October 5, 2001
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn diseaseJ D Rioux, M J Daly, M S Silverberg, et al.
Nature Genetics|February 10, 2015
The genomic and phenotypic diversity of Schizosaccharomyces pombeDaniel C Jeffares, Charalampos Rallis, Adrien Rieux, et al.
Nature Communications|August 10, 2016
A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitisManuel A Rivas, Daniel Graham, Patrick Sulem, et al.
Pageof 7